HemaCare Corporation (OTC Bulletin Board: HEMA) has appointed Pete van der Wal as its President and CEO. Van der Wal will assume his position as CEO immediately. He will replace John Doumitt, who resigned from the company as of February 26, 2010. Van der Wal, who will also join the HemaCare Board of Directors, was previously the company’s VP, Sales & Marketing.
Top Best Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign up for our Free Stock Newsletter.
Founded in 1978, HemaCare Corporation is a provider of blood products and therapeutic services to the healthcare industry. Licensed by the FDA and accredited by the AABB, the Company focuses on the customized collection and delivery of human blood-related products.
Sign up for Top Best Penny Stocks' free newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
Follow us on Twitter: http://www.Twitter.com/topbestps
About Us
Top Best Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
